创新药沪港深ETF昨日大涨5%,信达生物涨超17%,机构:优化药品集采政策有助于仿制药企稳定利润预期

21世纪经济报道
28 Mar

创新药板块昨日(3月27日)大幅反弹。相关ETF中,创新药沪港深ETF(517380)昨日大涨5%。资金流向方面,金融终端数据显示,该ETF连续5个交易日获资金净流入,累计“吸金”超1.2亿元。成分股方面,重仓股昨日普遍上涨,信达生物涨超17%,药明康德、恒瑞医药、百济神州、科伦生物、中国生物制药、新和成等多股上涨。创新药沪港深ETF(517380)紧密跟踪恒生沪深港创新药精选50指数,该指数追踪...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10